Delivery Order 36F79725D0061-15B50926F00000087
Award Date 9/1/26
Potential Completion Date 9/30/26
Potential Value $6K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Iselin, NJ 08830, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Helsinn Therapeutics (U.S.), Inc. was awarded a delivery order valued at $5,984.59 on May 1, 2026, by the Federal Correctional Institution Fort Worth for the supply of VALCHLOR gel, a pharmaceutical product used to treat cutaneous T-cell lymphoma. This firm fixed-price delivery order, with an ultimate completion date of May 30, 2026, carries no set-aside designation and will be fulfilled from the vendor's position on the Pharmaceuticals and Drugs (FSS-61-IB) General Services Administration...
- The Federal Correctional Institution Fort Worth issued a $5,984.59 delivery order to Helsinn Therapeutics (U.S.), Inc. on February 1, 2026, under the GSA Schedule Pharmaceuticals and Drugs (FSS-61-IB) for VALCHLOR gel, a specialized oncology pharmaceutical for cutaneous T-cell lymphoma treatment. The GSA Schedule carries a $33.57 million ceiling through February 2030 and supports pharmaceutical procurement across federal agencies. Place of performance is Iselin, New Jersey. The order is priced...
- Helsinn Therapeutics (U.S.), Inc. was awarded a delivery order valued at $5,984.59 by the Federal Medical Center Carswell on January 31, 2026, with completion scheduled for February 24, 2026. This firm fixed-price delivery order falls under the Pharmaceuticals and Drugs (FSS-61-IB) General Services Administration Schedule and carries no set-aside designation. The order represents a purchase from Helsinn's existing Federal Supply Schedule contract, which maintains a ceiling value of $33.6 million...
- The Federal Correctional Institution Fort Worth awarded a $548,689.83 firm fixed-price delivery order to Takeda Pharmaceuticals America Inc. on April 1, 2026, with a completion date of September 30, 2026. This delivery order, issued under no set-aside designation, procures specialized pharmaceutical products for federal correctional healthcare operations. The award is a child contract under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB), leveraging pre-negotiated pricing and terms...
- The Federal Correctional Institution Fort Worth awarded a $148,019.16 firm fixed-price delivery order to Takeda Pharmaceuticals America Inc. on October 1, 2025, with an ultimate completion date of January 30, 2026. This delivery order, issued under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB), represents a child contract to Takeda's broader single-award Blanket Purchase Agreement with the Department of Veterans Affairs National Acquisition Center valued at $131.0 million for the period...
- Actelion Pharmaceuticals US, Inc. has been awarded a delivery order valued at $61,988.37 under the FY26 Pharmacy March procurement, with an ultimate completion date of March 31, 2026. This firm fixed-price delivery order was issued by the Federal Correctional Institution Fort Worth on March 1, 2026, with no small business set-aside designation. The contract represents a continuation of pharmaceutical supply services under Actelion's existing Federal Supply Schedule contract (FSS-61-IB) for...
- <p>The Federal Correctional Complex Florence issued a $14,385.75 delivery order to Takeda Pharmaceuticals America, Inc. on March 1, 2026, under the GSA Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), for foundation care pharmacy chemotherapy supplies with an ultimate completion date of March 31, 2026.</p> <p>Place of performance is Sand Lake, FL. The order is firm fixed-price with no set-aside designation.</p>
- The Federal Correctional Institution Fort Worth issued a $77,052.81 delivery order to Actelion Pharmaceuticals US, Inc. on June 1, 2026, under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) for Uptravi and Opsumit pharmaceutical products with a completion date of June 30, 2026. Place of performance is Titusville, Hopewell Township, New Jersey. The order is firm fixed price with no set-aside. This represents recurring monthly ordering for pulmonary arterial hypertension...
- Takeda Pharmaceuticals America Inc. received a $319,551.93 firm fixed-price delivery order from the Federal Correctional Institution Fort Worth on October 1, 2025, with performance completion targeted for September 30, 2026. This delivery order, issued under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB), represents a child contract leveraging pre-negotiated terms and pricing established through Takeda's broader federal contracting vehicles. The award carries no set-aside designation,...
- This is a firm fixed price delivery order awarded by the Federal Correctional Institution (FCI) Fort Worth, which is part of the U.S. Department of Justice, to the prime contractor Mckesson Corporation. The delivery order, valued at $125,240.25, is for the provision of medication to the FCI for the month of June 2015. This delivery order was placed against a larger indefinite delivery/indefinite quantity (IDIQ) contract vehicle, VA797P-12-D-0001, held by Mckesson. The contract does not have a...